IL-17 is highly expressed in the serum and tissues of patients with various autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and ankylosing spondylitis [19–23], and is closely related to the pathogenesis of autoimmune and inflammatory diseases. Here, IL17A is linked to systemic lupus erythematosus.